Back
Arcturus Therapeutics Holdings, Inc. Stock Predictions
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
32
ARCT
Arcturus Therapeutics Holdings, Inc.
Last Price:
$7.48
Seasonality Move:
8.28%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis NowArcturus Therapeutics Holdings, Inc. Stock Forecast
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 31.6% based on the past 12 years of stock performance.
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Arcturus Therapeutics Holdings, Inc. Stock Undervalued?The current Arcturus Therapeutics Holdings, Inc. [ARCT] share price is $7.47. The Score for ARCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Arcturus Therapeutics Holdings, Inc. has on average historically risen by 31.6% based on the past 12 years of stock performance.
Arcturus Therapeutics Holdings, Inc. Stock Rating
Sell
32
Arcturus Therapeutics Holdings, Inc. (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings, Inc. overpriced?
-
Arcturus Therapeutics Holdings, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Arcturus Therapeutics Holdings, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
24.17
52-Week Low:
5.85
Prediction Charts
Market Cap:
212.2M
Price in USD:
7.47
Volume:
469.1K
Beta:
2.50
Technical Analysis
SMA50:
6.91
SMA100:
11.65
SMA200:
12.54
52-Wk Change:
-57.12%
Stock Predictions
-
Is Arcturus Therapeutics Holdings, Inc. stock public?Yes, Arcturus Therapeutics Holdings, Inc. is a publicly traded company.
-
What is the Arcturus Therapeutics Holdings, Inc. stock quote today?The Arcturus Therapeutics Holdings, Inc. stock price is 7.47 USD today.
-
How to buy Arcturus Therapeutics Holdings, Inc. stock online?You can buy Arcturus Therapeutics Holdings, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-12 | 7.08 | 7.53 | 7.57 | 6.91 |
| Jan-13 | 7.61 | 7.57 | 7.93 | 7.48 |
| Jan-14 | 7.56 | 7.73 | 7.79 | 7.42 |
| Jan-15 | 7.78 | 7.61 | 7.82 | 7.45 |
| Jan-16 | 7.60 | 7.29 | 7.74 | 7.29 |
| Jan-20 | 7.01 | 7.10 | 7.28 | 6.95 |
| Jan-21 | 7.05 | 7.27 | 7.35 | 7.00 |
| Jan-22 | 7.36 | 7.59 | 7.89 | 7.32 |
| Jan-23 | 7.70 | 7.53 | 7.77 | 7.41 |
| Jan-26 | 7.50 | 7.36 | 7.50 | 7.27 |
| Jan-27 | 7.40 | 7.46 | 7.59 | 7.33 |
| Jan-28 | 7.50 | 7.37 | 7.62 | 7.28 |
| Jan-29 | 7.37 | 7.57 | 7.70 | 7.24 |
| Jan-30 | 7.47 | 7.47 | 7.60 | 7.18 |
Arcturus Therapeutics Holdings, Inc. Earnings
Arcturus Therapeutics Holdings, Inc. Earnings Report: Per Share Arcturus Therapeutics Holdings, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings, Inc. Forecast Revenue Growth
Arcturus Therapeutics Holdings, Inc. Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $2.05 per share.
* Arcturus Therapeutics Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.